Page last updated: 2024-10-27

foscarnet and Viral Hepatitis, Human

foscarnet has been researched along with Viral Hepatitis, Human in 7 studies

Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.

Research Excerpts

ExcerptRelevanceReference
" The first developed three episodes of cytomegaloviremia requiring anti-viral therapy; the third episode accompanied by cytomegalovirus hepatitis which required prolonged therapy with foscarnet."3.69Unusual infections following allogeneic bone marrow transplantation for chronic lymphocytic leukemia. ( Brincat, S; Catovsky, D; Iveson, T; Jameson, B; Mehta, J; Paul, B; Powles, R; Singhal, S; Treleaven, J; Zomas, A, 1994)
" The patient also suffered from recurrent cytomegalovirus (CMV) viremia, treated with foscarnet and ganciclovir."3.69Successful allogeneic bone marrow transplantation in a 2.5-year-old boy with ongoing cytomegalovirus viremia and severe aplastic anemia after orthotopic liver transplantation for non-A, non-B, non-C hepatitis. ( Ericzon, BG; Hägglund, H; Ringdén, O; Sparrelid, E; Winiarski, J, 1997)
" In patients with renal insufficiency, careful dosage adjustment is mandatory to optimize drug exposure and reduce the risk for adverse events."2.41Anti-viral drugs in continuous ambulatory peritoneal dialysis (CAPD). ( Deray, G; Issad, B; Izzedine, H; Launay-Vacher, V, 2002)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's3 (42.86)18.2507
2000's2 (28.57)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gutierrez, C1
Kebriaei, P1
Turner, KA1
Yemelyanova, A1
Ariza-Heredia, EJ1
Foo, WC1
Ganner, A1
Lee, YM1
Busche, C1
Schmitt-Graeff, A1
Encke, J1
Walz, G1
Gerke, P1
Zomas, A1
Mehta, J1
Powles, R1
Treleaven, J1
Iveson, T1
Singhal, S1
Jameson, B1
Paul, B1
Brincat, S1
Catovsky, D1
Fujisaki, T1
Gondo, H1
Uchida, N1
Matsuo, I1
Takenaka, K1
Tanimoto, K1
Otsuka, T1
Minematsu, T1
Minamishima, Y1
Niho, Y1
Hägglund, H1
Winiarski, J1
Ringdén, O1
Sparrelid, E1
Ericzon, BG2
Izzedine, H1
Launay-Vacher, V1
Issad, B1
Deray, G1
Weiland, O1
Andersson, J1
Hultcrantz, R1
Stiernstedt, G1

Reviews

1 review available for foscarnet and Viral Hepatitis, Human

ArticleYear
Anti-viral drugs in continuous ambulatory peritoneal dialysis (CAPD).
    Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 2002, Volume: 54, Issue:2

    Topics: Adamantane; Anti-HIV Agents; Antimetabolites; Antiviral Agents; Dideoxynucleosides; Foscarnet; Hepat

2002

Other Studies

6 other studies available for foscarnet and Viral Hepatitis, Human

ArticleYear
A unique presentation of acute liver failure from herpes simplex virus hepatitis.
    Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:4

    Topics: Acyclovir; Adrenal Cortex Hormones; Antiviral Agents; Bone Marrow Transplantation; Drug Resistance,

2016
Successful liver transplantation in a kidney and pancreas allograft recipient with fulminant herpes simplex virus type 2 hepatitis.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22, Issue:11

    Topics: Acyclovir; Adult; Antiviral Agents; Biopsy, Needle; Female; Foscarnet; Hepatitis, Viral, Human; Herp

2007
Unusual infections following allogeneic bone marrow transplantation for chronic lymphocytic leukemia.
    Bone marrow transplantation, 1994, Volume: 14, Issue:5

    Topics: Adult; Anti-Bacterial Agents; Bone Marrow Transplantation; Cytomegalovirus Infections; Drug Therapy,

1994
[Foscarnet therapy for ganciclovir-refractory cytomegalovirus hepatitis in a patient who underwent bone marrow transplantation from an unrelated donor].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1997, Volume: 38, Issue:2

    Topics: Adult; Antiviral Agents; Bone Marrow Transplantation; Combined Modality Therapy; Cytomegalovirus Inf

1997
Successful allogeneic bone marrow transplantation in a 2.5-year-old boy with ongoing cytomegalovirus viremia and severe aplastic anemia after orthotopic liver transplantation for non-A, non-B, non-C hepatitis.
    Transplantation, 1997, Oct-27, Volume: 64, Issue:8

    Topics: Anemia, Aplastic; Antiviral Agents; Biopsy; Bone Marrow; Bone Marrow Transplantation; Child, Prescho

1997
[New therapeutic possibilities in fulminant viral hepatitis].
    Lakartidningen, 1989, Mar-01, Volume: 86, Issue:9

    Topics: Foscarnet; Hepatitis, Viral, Human; Humans; Liver Transplantation; Phosphonoacetic Acid; Prognosis

1989